Microglia, the resident immune cell of the brain, can be eliminated via pharmacological inhibition of the colony-stimulating factor 1 receptor (CSF1R). Withdrawal of CSF1R inhibition then stimulates microglial repopulation, effectively replacing the microglial compartment. In the aged brain, microglia take on a "primed" phenotype and studies indicate that this coincides with age-related cognitive decline. Here, we investigated the effects of replacing the aged microglial compartment with new microglia using CSF1R inhibitor-induced microglial repopulation. With 28 days of repopulation, replacement of resident microglia in aged mice (24 months) improved spatial memory and restored physical microglial tissue characteristics (cell densities and morphologies) to those found in young adult animals (4 months). However, inflammation-related gene expression was not broadly altered with repopulation nor the response to immune challenges. Instead, microglial repopulation resulted in a reversal of age-related changes in neuronal gene expression, including expression of genes associated with actin cytoskeleton remodeling and synaptogenesis. Age-related changes in hippocampal neuronal complexity were reversed with both microglial elimination and repopulation, while microglial elimination increased both neurogenesis and dendritic spine densities. These changes were accompanied by a full rescue of age-induced deficits in long-term potentiation with microglial repopulation. Thus, several key aspects of the aged brain can be reversed by acute noninvasive replacement of microglia.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260908PMC
http://dx.doi.org/10.1111/acel.12832DOI Listing

Publication Analysis

Top Keywords

microglial repopulation
16
aged brain
12
microglial
9
replacement microglia
8
microglia aged
8
microglial compartment
8
gene expression
8
age-related changes
8
microglial elimination
8
repopulation
7

Similar Publications

Article Synopsis
  • CSF1R inhibitors can deplete and rejuvenate microglia in the brain, potentially improving conditions like Alzheimer's disease (AD).
  • The study used 5xFAD mice to investigate how microglial depletion and repopulation affect amyloid plaque progression and found temporary improvements in plaque burden.
  • Although the improvements weren't lasting, renewing microglia late in disease progression may enhance their responsiveness to noradrenergic signaling, suggesting a possible therapeutic approach for AD.
View Article and Find Full Text PDF

A growing body of evidence highlights the importance of microglia, the resident immune cells of the CNS, and their pro-inflammatory activation in the onset of many neurological diseases. Microglial proliferation, differentiation, and survival are highly dependent on the CSF-1 signaling pathway, which can be pharmacologically modulated by inhibiting its receptor, CSF-1R. Pharmacological inhibition of CSF-1R leads to an almost complete microglial depletion whereas treatment arrest allows for subsequent repopulation.

View Article and Find Full Text PDF

Neuro-immunobiology and treatment assessment in a mouse model of anti-NMDAR encephalitis.

Brain

December 2024

Neuroimmunology Program, Fundació Clínic per la Recerca Biomèdica - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FCRB-IDIBAPS), Barcelona 08036, Spain.

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a disorder mediated by autoantibodies against the GluN1 subunit of NMDAR. It occurs with severe neuropsychiatric symptoms that often improve with immunotherapy. Clinical studies and animal models based on patients' antibody transfer or NMDAR immunization suggest that the autoantibodies play a major pathogenic role.

View Article and Find Full Text PDF

Background: Reactive astrogliosis and microgliosis are coordinated responses to CNS insults and are pathological hallmarks of traumatic brain injury (TBI). In these conditions, persistent reactive gliosis can impede tissue repopulation and limit neurogenesis. Thus, modulating this phenomenon has been increasingly recognized as potential therapeutic approach.

View Article and Find Full Text PDF
Article Synopsis
  • - Microglia play a key role in regulating cerebral blood flow (CBF), particularly during activities like whisker stimulation or ATP injection, affecting both baseline levels and increases in blood flow.
  • - Depleting microglia reduces activity-dependent blood flow responses, but the body still responds normally to other stimuli like adenosine, indicating a specific function for microglia in this process.
  • - The regulation of CBF by microglia involves the ATP-sensing receptor P2ry12 and the enzyme CD39, which converts extracellular ATP into adenosine, crucial for neurovascular coupling and maintaining healthy blood flow responses.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!